Click for best price

Oncology Small Molecule Drugs Market Size, Share 2022

Market Analysis and Insights: Global Oncology Small Molecule Drugs Market

The global Oncology Small Molecule Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Small Molecule Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Small Molecule Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Small Molecule Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Small Molecule Drugs market.

Global Oncology Small Molecule Drugs Scope and Market Size

Oncology Small Molecule Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Oncology Small Molecule Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Chemotherapy Drugs

Immunomodulating Drugs

Targeted Therapy Drugs

Hormonal Therapy

Other

Segment by Application

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Lung Cancer

Other

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Roche

Novartis

Pfizer

Celgene

Bristol-Myers Squibb

Amgen

Johnson & Johnson

AbbVie

Sanofi

Takeda

Eli Lilly

Bayer

AstraZeneca

Astellas

Merck

Biogen Idec

Eisai

Teva

Otsuka

Ipsen

Gilead Sciences

Exelixis

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Oncology Small Molecule Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Oncology Small Molecule Drugs, with price, sales, revenue, and global market share of Oncology Small Molecule Drugs from 2019 to 2022.

Chapter 3, the Oncology Small Molecule Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Oncology Small Molecule Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Oncology Small Molecule Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Small Molecule Drugs.

Chapter 13, 14, and 15, to describe Oncology Small Molecule Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Oncology Small Molecule Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Oncology Small Molecule Drugs Market Research Report 2022
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	108 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Chemotherapy Drugs
1.2.3 Immunomodulating Drugs
1.2.4 Targeted Therapy Drugs
1.2.5 Hormonal Therapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Oncology Small Molecule Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Lung Cancer
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Small Molecule Drugs Market Perspective (2017-2028)
2.2 Oncology Small Molecule Drugs Growth Trends by Region
2.2.1 Oncology Small Molecule Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oncology Small Molecule Drugs Historic Market Size by Region (2017-2022)
2.2.3 Oncology Small Molecule Drugs Forecasted Market Size by Region (2023-2028)
2.3 Oncology Small Molecule Drugs Market Dynamics
2.3.1 Oncology Small Molecule Drugs Industry Trends
2.3.2 Oncology Small Molecule Drugs Market Drivers
2.3.3 Oncology Small Molecule Drugs Market Challenges
2.3.4 Oncology Small Molecule Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Small Molecule Drugs Players by Revenue
3.1.1 Global Top Oncology Small Molecule Drugs Players by Revenue (2017-2022)
3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Oncology Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Small Molecule Drugs Revenue
3.4 Global Oncology Small Molecule Drugs Market Concentration Ratio
3.4.1 Global Oncology Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Small Molecule Drugs Revenue in 2021
3.5 Oncology Small Molecule Drugs Key Players Head office and Area Served
3.6 Key Players Oncology Small Molecule Drugs Product Solution and Service
3.7 Date of Enter into Oncology Small Molecule Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Small Molecule Drugs Breakdown Data by Type
4.1 Global Oncology Small Molecule Drugs Historic Market Size by Type (2017-2022)
4.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2023-2028)
5 Oncology Small Molecule Drugs Breakdown Data by Application
5.1 Global Oncology Small Molecule Drugs Historic Market Size by Application (2017-2022)
5.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oncology Small Molecule Drugs Market Size (2017-2028)
6.2 North America Oncology Small Molecule Drugs Market Size by Country (2017-2022)
6.3 North America Oncology Small Molecule Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Oncology Small Molecule Drugs Market Size (2017-2028)
7.2 Europe Oncology Small Molecule Drugs Market Size by Country (2017-2022)
7.3 Europe Oncology Small Molecule Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Small Molecule Drugs Market Size (2017-2028)
8.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Oncology Small Molecule Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Oncology Small Molecule Drugs Market Size (2017-2028)
9.2 Latin America Oncology Small Molecule Drugs Market Size by Country (2017-2022)
9.3 Latin America Oncology Small Molecule Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Small Molecule Drugs Market Size (2017-2028)
10.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Small Molecule Drugs Introduction
11.1.4 Roche Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Oncology Small Molecule Drugs Introduction
11.2.4 Novartis Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oncology Small Molecule Drugs Introduction
11.3.4 Pfizer Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Celgene
11.4.1 Celgene Company Detail
11.4.2 Celgene Business Overview
11.4.3 Celgene Oncology Small Molecule Drugs Introduction
11.4.4 Celgene Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.4.5 Celgene Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Introduction
11.5.4 Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Oncology Small Molecule Drugs Introduction
11.6.4 Amgen Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.6.5 Amgen Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.7.5 Johnson & Johnson Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Oncology Small Molecule Drugs Introduction
11.8.4 AbbVie Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.8.5 AbbVie Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Oncology Small Molecule Drugs Introduction
11.9.4 Sanofi Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.9.5 Sanofi Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Oncology Small Molecule Drugs Introduction
11.10.4 Takeda Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.10.5 Takeda Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Detail
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Oncology Small Molecule Drugs Introduction
11.11.4 Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.11.5 Eli Lilly Recent Development
11.12 Bayer
11.12.1 Bayer Company Detail
11.12.2 Bayer Business Overview
11.12.3 Bayer Oncology Small Molecule Drugs Introduction
11.12.4 Bayer Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.12.5 Bayer Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Detail
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Oncology Small Molecule Drugs Introduction
11.13.4 AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.13.5 AstraZeneca Recent Development
11.14 Astellas
11.14.1 Astellas Company Detail
11.14.2 Astellas Business Overview
11.14.3 Astellas Oncology Small Molecule Drugs Introduction
11.14.4 Astellas Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.14.5 Astellas Recent Development
11.15 Merck
11.15.1 Merck Company Detail
11.15.2 Merck Business Overview
11.15.3 Merck Oncology Small Molecule Drugs Introduction
11.15.4 Merck Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.15.5 Merck Recent Development
11.16 Biogen Idec
11.16.1 Biogen Idec Company Detail
11.16.2 Biogen Idec Business Overview
11.16.3 Biogen Idec Oncology Small Molecule Drugs Introduction
11.16.4 Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.16.5 Biogen Idec Recent Development
11.17 Eisai
11.17.1 Eisai Company Detail
11.17.2 Eisai Business Overview
11.17.3 Eisai Oncology Small Molecule Drugs Introduction
11.17.4 Eisai Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.17.5 Eisai Recent Development
11.18 Teva
11.18.1 Teva Company Detail
11.18.2 Teva Business Overview
11.18.3 Teva Oncology Small Molecule Drugs Introduction
11.18.4 Teva Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.18.5 Teva Recent Development
11.19 Otsuka
11.19.1 Otsuka Company Detail
11.19.2 Otsuka Business Overview
11.19.3 Otsuka Oncology Small Molecule Drugs Introduction
11.19.4 Otsuka Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.19.5 Otsuka Recent Development
11.20 Ipsen
11.20.1 Ipsen Company Detail
11.20.2 Ipsen Business Overview
11.20.3 Ipsen Oncology Small Molecule Drugs Introduction
11.20.4 Ipsen Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.20.5 Ipsen Recent Development
11.21 Gilead Sciences
11.21.1 Gilead Sciences Company Detail
11.21.2 Gilead Sciences Business Overview
11.21.3 Gilead Sciences Oncology Small Molecule Drugs Introduction
11.21.4 Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.21.5 Gilead Sciences Recent Development
11.22 Exelixis
11.22.1 Exelixis Company Detail
11.22.2 Exelixis Business Overview
11.22.3 Exelixis Oncology Small Molecule Drugs Introduction
11.22.4 Exelixis Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.22.5 Exelixis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Chemotherapy Drugs
Table 3. Key Players of Immunomodulating Drugs
Table 4. Key Players of Targeted Therapy Drugs
Table 5. Key Players of Hormonal Therapy
Table 6. Key Players of Other
Table 7. Global Oncology Small Molecule Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Oncology Small Molecule Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Oncology Small Molecule Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Oncology Small Molecule Drugs Market Share by Region (2017-2022)
Table 11. Global Oncology Small Molecule Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Oncology Small Molecule Drugs Market Share by Region (2023-2028)
Table 13. Oncology Small Molecule Drugs Market Trends
Table 14. Oncology Small Molecule Drugs Market Drivers
Table 15. Oncology Small Molecule Drugs Market Challenges
Table 16. Oncology Small Molecule Drugs Market Restraints
Table 17. Global Oncology Small Molecule Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Oncology Small Molecule Drugs Market Share by Players (2017-2022)
Table 19. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2021)
Table 20. Ranking of Global Top Oncology Small Molecule Drugs Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Oncology Small Molecule Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Small Molecule Drugs Product Solution and Service
Table 24. Date of Enter into Oncology Small Molecule Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2017-2022)
Table 28. Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2023-2028)
Table 30. Global Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Oncology Small Molecule Drugs Revenue Market Share by Application (2017-2022)
Table 32. Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Oncology Small Molecule Drugs Revenue Market Share by Application (2023-2028)
Table 34. North America Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Roche Company Detail
Table 45. Roche Business Overview
Table 46. Roche Oncology Small Molecule Drugs Product
Table 47. Roche Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 48. Roche Recent Development
Table 49. Novartis Company Detail
Table 50. Novartis Business Overview
Table 51. Novartis Oncology Small Molecule Drugs Product
Table 52. Novartis Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Oncology Small Molecule Drugs Product
Table 57. Pfizer Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Celgene Company Detail
Table 60. Celgene Business Overview
Table 61. Celgene Oncology Small Molecule Drugs Product
Table 62. Celgene Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 63. Celgene Recent Development
Table 64. Bristol-Myers Squibb Company Detail
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Oncology Small Molecule Drugs Product
Table 67. Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Amgen Company Detail
Table 70. Amgen Business Overview
Table 71. Amgen Oncology Small Molecule Drugs Product
Table 72. Amgen Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. Johnson & Johnson Company Detail
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Oncology Small Molecule Drugs Product
Table 77. Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. AbbVie Company Detail
Table 80. AbbVie Business Overview
Table 81. AbbVie Oncology Small Molecule Drugs Product
Table 82. AbbVie Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 83. AbbVie Recent Development
Table 84. Sanofi Company Detail
Table 85. Sanofi Business Overview
Table 86. Sanofi Oncology Small Molecule Drugs Product
Table 87. Sanofi Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. Takeda Company Detail
Table 90. Takeda Business Overview
Table 91. Takeda Oncology Small Molecule Drugs Product
Table 92. Takeda Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 93. Takeda Recent Development
Table 94. Eli Lilly Company Detail
Table 95. Eli Lilly Business Overview
Table 96. Eli Lilly Oncology Small Molecule DrugsProduct
Table 97. Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 98. Eli Lilly Recent Development
Table 99. Bayer Company Detail
Table 100. Bayer Business Overview
Table 101. Bayer Oncology Small Molecule DrugsProduct
Table 102. Bayer Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 103. Bayer Recent Development
Table 104. AstraZeneca Company Detail
Table 105. AstraZeneca Business Overview
Table 106. AstraZeneca Oncology Small Molecule DrugsProduct
Table 107. AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 108. AstraZeneca Recent Development
Table 109. Astellas Company Detail
Table 110. Astellas Business Overview
Table 111. Astellas Oncology Small Molecule DrugsProduct
Table 112. Astellas Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 113. Astellas Recent Development
Table 114. Merck Company Detail
Table 115. Merck Business Overview
Table 116. Merck Oncology Small Molecule DrugsProduct
Table 117. Merck Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 118. Merck Recent Development
Table 119. Biogen Idec Company Detail
Table 120. Biogen Idec Business Overview
Table 121. Biogen Idec Oncology Small Molecule DrugsProduct
Table 122. Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 123. Biogen Idec Recent Development
Table 124. Eisai Company Detail
Table 125. Eisai Business Overview
Table 126. Eisai Oncology Small Molecule DrugsProduct
Table 127. Eisai Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 128. Eisai Recent Development
Table 129. Teva Company Detail
Table 130. Teva Business Overview
Table 131. Teva Oncology Small Molecule DrugsProduct
Table 132. Teva Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 133. Teva Recent Development
Table 134. Otsuka Company Detail
Table 135. Otsuka Business Overview
Table 136. Otsuka Oncology Small Molecule DrugsProduct
Table 137. Otsuka Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 138. Otsuka Recent Development
Table 139. Ipsen Company Detail
Table 140. Ipsen Business Overview
Table 141. Ipsen Oncology Small Molecule DrugsProduct
Table 142. Ipsen Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 143. Ipsen Recent Development
Table 144. Gilead Sciences Company Detail
Table 145. Gilead Sciences Business Overview
Table 146. Gilead Sciences Oncology Small Molecule DrugsProduct
Table 147. Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 148. Gilead Sciences Recent Development
Table 149. Exelixis Company Detail
Table 150. Exelixis Business Overview
Table 151. Exelixis Oncology Small Molecule DrugsProduct
Table 152. Exelixis Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 153. Exelixis Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Small Molecule Drugs Market Share by Type: 2021 VS 2028
Figure 2. Chemotherapy Drugs Features
Figure 3. Immunomodulating Drugs Features
Figure 4. Targeted Therapy Drugs Features
Figure 5. Hormonal Therapy Features
Figure 6. Other Features
Figure 7. Global Oncology Small Molecule Drugs Market Share by Application in 2021 & 2028
Figure 8. Blood Cancer Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Gastrointestinal Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Lung Cancer Case Studies
Figure 13. Other Case Studies
Figure 14. Oncology Small Molecule Drugs Report Years Considered
Figure 15. Global Oncology Small Molecule Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Oncology Small Molecule Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Oncology Small Molecule Drugs Market Share by Region: 2021 VS 2028
Figure 18. Global Oncology Small Molecule Drugs Market Share by Players in 2021
Figure 19. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Oncology Small Molecule Drugs Revenue in 2021
Figure 21. North America Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. North America Oncology Small Molecule Drugs Market Share by Country (2017-2028)
Figure 23. United States Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Oncology Small Molecule Drugs Market Share by Country (2017-2028)
Figure 27. Germany Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Oncology Small Molecule Drugs Market Share by Region (2017-2028)
Figure 35. China Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Oncology Small Molecule Drugs Market Share by Country (2017-2028)
Figure 43. Mexico Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Brazil Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Oncology Small Molecule Drugs Market Share by Country (2017-2028)
Figure 47. Turkey Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Saudi Arabia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Roche Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 50. Novartis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 51. Pfizer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 52. Celgene Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 54. Amgen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 55. Johnson & Johnson Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 56. AbbVie Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 57. Sanofi Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 58. Takeda Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 59. Eli Lilly Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 60. Bayer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 62. Astellas Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 63. Merck Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 64. Biogen Idec Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 65. Eisai Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 66. Teva Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 67. Otsuka Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 68. Ipsen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 69. Gilead Sciences Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 70. Exelixis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Oncology Small Molecule Drugs Market Research Report 2022